QualityStocks Stock Newsletters Archives - Page 360 of 1818

ThursdayNov 18, 2010 1:21 pm

Bond Laboratories (BNLB.OB) Positions Itself for Growth; Pump Fuel® Sales Up 50% in October

Bond Laboratories, Inc. yesterday detailed the completion of equity financing which should help position the company for continued growth by providing additional resources and stability. With the financing now in place, the company will be able to continue its aggressive business strategies with the intentions of operating “in the black” next year. A portion of the new financing deal included the company raising additional equity capital through a private placement with net proceeds of $1.25 million through the issuance of a newly-created Series C Convertible Preferred Stock. Highlights on the financing included: • Holders representing more than 50% of the…

ThursdayNov 18, 2010 10:49 am

China Advanced Construction Materials Group (CADC) Signs LOI with China State Construction Engineering Corp.

China Advanced Construction Materials Group, a leading provider of ready-mix concrete and related technical services in China, announced today that it has signed a letter of intent with China State Construction Engineering Corporation. Under the agreement, China ACM will be the preferred provider of its eco-friendly ready-mix concrete and associated engineering services, and both companies will cooperate strategically in international and national markets, sharing resources to increase competitiveness in the global construction market. China State Construction Engineering Corp. Ltd. is the most competitive building enterprise group in China, from housing construction to international building contracting, real estate development and investment,…

ThursdayNov 18, 2010 10:27 am

IceWEB, Inc. (IWEB.OB) Video Chart for Thursday, November 18, 2010

IWEB has made significant climbs throughout the year. At this point it is holding a support level around 20 cents and is on radar to continue to hold this base and possibly make another climb. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

ThursdayNov 18, 2010 10:14 am

Adama Technologies Corp (ADAC.OB) Projects Substantial Revenue Growth, Drops Merger Activities to Ensure Profit Retention for Shareholders

Adama Technologies, www.adama-tech.com – developers of the revolutionary MBS (molecular bonding system) technology which is capable of providing a long-term answer to inestimably dangerous heavy metal waste pollution, projected extremely positive 2011 financial growth data today: • Revenue $8M • Gross Profit 40% or roughly $4M • Net Income $3M Projected revenue growth for 2011 is expected to exceed even today’s projections subsequent to pending approval of the MBS technology by Israel’s IEPA, thus securing even more territory for ADAC, which is already developing in Romania and surrounding countries. Adama’s MBS technology can treat all RCRA/UTS-defined (Resource and Recovery Act,…

ThursdayNov 18, 2010 10:10 am

China Kangtai Cactus Biotech Inc. (CKGT.OB) Reports Financial Results for Third Quarter 2010

China Kangtai Cactus Biotech Inc. announced yesterday that its 2010 third quarter revenue increased by 16.3% to $9.5 million from the same period last year. The company also reported a gain in net income, which went up 889% to $8.2 million, or $0.13 per diluted share. China Kangtai Cactus Biotech posted a variety of financial statistics, giving a general overview of its performance. Gross profit margin was 38% compared with 40% in the third quarter of 2009. Income from operations decreased from $3.5 million in 2009 to $3.1 million. Weighted average number of diluted shares outstanding was 21.6 million for…

ThursdayNov 18, 2010 10:05 am

PolyMedix, Inc. (PYMX.OB) Appoints Steffen Helmling as VP of Business Development

Yesterday, PolyMedix, Inc. announced the appointment of Steffen Helmling, Ph.D. as their new Vice President of Business Development. Dr. Helmling will be responsible for new development initiatives, such as partnering and licensing for PolyMedix's products in development. PolyMedix is a biotech company focused on developing new pharmaceuticals for the treatment of infectious diseases and cardiovascular disorders. PolyMedix's lead antibiotic, MX-30063, is in Phase 2 clinical trials, and its lead heptagonist compound, PMX-60056, has completed Phase 1 trials. Their PolyCides products are intended to be used as additives to such items as paints, plastic and textile to create self-sterilizing surfaces. Dr.…

WednesdayNov 17, 2010 3:26 pm

PositiveID Corp. (PSID) Launches “The Wireless Body™” Embedded Bio-Sensor System for Diabetes Applications

PositiveID, www.positiveidcorp.com – developers of implantable RFID diagnostic/identification technology and disease management tools for the healthcare industry, reported the launch of its The Wireless Body™ system at the ID WORLD International Congress in Milan. The Wireless Body system was designed to be a fully integrated, smart health communication system for diabetics, allowing for real-time management capabilities, but the system also has tremendous future potential as a management platform for other diseases. Unprecedented wireless access to the patient’s vitals and data means that The Wireless Body constitutes a new paradigm in disease management systems. The age of personalized medicine moves ever…

WednesdayNov 17, 2010 3:20 pm

Access Pharmaceuticals, Inc. (ACCP.OB) Presenting Posters at the Innovations in Cancer Prevention and Research Conference

Access Pharmaceuticals, Inc. will be displaying posters on its novel developments in drug delivery platforms for cancer therapy this week at the Innovations in Cancer Prevention and Research Conference at the Austin Convention Center in Austin, TX. The Inaugural Conference is being held November 17-19, 2010 and is hosted by the rapidly-growing Cancer Prevention and Research Institute of Texas whose mission is to “create and support infrastructure in Texas that accelerates the movement of new cancer drugs, diagnostics, and therapies from the laboratory to the patient.” Access Pharmaceuticals will be presenting two posters at the event. Poster “Vitamin B-12 Nanoparticles…

WednesdayNov 17, 2010 3:16 pm

China TMK Battery Systems Inc. (DFEL) Reports Third Quarter 2010 Results

China TMK Battery Systems Inc. reported large year over year increases in revenue and net income as the company benefited from strong demand for its products. China TMK Battery Systems Inc. reported sales of $16.5 million in the quarter ending 9/30/2010, a 27% increase from the $13 million reported in the same quarter of 2009. China TMK Battery Systems Inc. reported net income of $3.1 million, or $0.08 per diluted share, in the third quarter of 2010. The company earned net income of $1.1 million, or $0.08 per diluted share, in the third quarter of 2009. The management of China…

WednesdayNov 17, 2010 3:12 pm

Intellipharmaceutics International, Inc. (IPCI) Appoints New Chief Financial Officer

On November 29, 2010, Intellipharmaceutics International, Inc. will have newly-appointed Shameze Rampertab stepping-in to serve as the company’s new Chief Financial Officer, replacing the recently resigned Graham Neil. Mr. Neil recently stepped-down to pursue other business opportunities. Mr. Rampertab will be bringing a highly-relevant skill set with him to the Intellipharmaceutics’ team. A chartered accountant for nearly twenty years, he has senior-level executive experience in many aspects of biotechnology and related finance fields, including licensing and royalty agreements, through his previous positions at companies such as Drug Royalty Corporation, where he served as Director as well as Finance and Secretary-Treasurer.…

Site Search

Company Search

Category: QualityStocks Stock Newsletters